
Ekso Bionics Holdings EKSO
$ 9.45
4.77%
Annual report 2025
added 02-23-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
2.43 M |
Market Cap[1] |
$ 22.9 M |
EBITDA (LTM) |
$ -13 M |
P/E (LTM) |
- |
P/S (LTM) |
1.51 |
EPS (LTM) |
-3.45 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 28.41 | 0.62 % | $ 1.36 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 59.45 | 3.74 % | $ 2.99 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 79.8 | 2.29 % | $ 40.4 B | NYSE | ||
|
The Cooper Companies
COO
|
$ 71.47 | 0.37 % | $ 14.2 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.32 | 2.61 % | $ 200 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.37 | -8.69 % | $ 109 M | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 4.57 | 6.03 % | $ 203 M | Nasdaq Global Market | ||
|
electroCore
ECOR
|
$ 6.33 | 4.03 % | $ 53.7 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 26.82 | 1.59 % | $ 4.51 B | NYSE | ||
|
Masimo Corporation
MASI
|
$ 178.4 | 0.04 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 52.45 | 1.88 % | $ 172 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 119.75 | 3.91 % | $ 3.83 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 5.42 % | $ 23.8 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 70.6 | 3.43 % | $ 4.18 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 3.73 % | $ 21 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 118.95 | 2.14 % | $ 5.76 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 129.06 | 2.69 % | $ 3.18 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.62 | 2.56 % | $ 199 M | NYSE American | ||
|
STERIS plc
STE
|
$ 223.62 | 0.48 % | $ 22 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 122.18 | 3.18 % | $ 5.45 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.43 | 2.31 % | $ 218 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 457.13 | 1.44 % | $ 163 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 114.61 | -0.01 % | $ 2.59 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.01 | 2.52 % | $ 2.39 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 20.17 | 2.18 % | $ 929 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 17.61 | 2.71 % | $ 9.03 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 229.2 | 0.21 % | $ 33.5 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 18.99 | 1.71 % | $ 1.28 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.93 | 3.21 % | $ 176 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 26.8 | 1.36 % | $ 1.33 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 257.01 | 0.19 % | $ 18.6 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.23 | 4.39 % | $ 418 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.22 | 0.7 % | $ 44.6 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.92 | -1.27 % | $ 30.3 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.11 | 5.07 % | $ 229 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 122.17 | 1.72 % | $ 6.81 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.